Pentobarbital sodium
Pentobarbital Sodium is a prescription injectable solution (50 mg/mL) used for intramuscular or intravenous administration. Manufactured by Hikma Pharmaceuticals USA Inc., it's a DEA Schedule II controlled substance for medical purposes like sedation or anesthesia. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Pentobarbital Sodium is a prescription injectable solution (50 mg/mL) used for intramuscular or intravenous administration. Manufactured by Hikma Pharmaceuticals USA Inc., it's a DEA Schedule II controlled substance for medical purposes like sedation or anesthesia. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Pentobarbital sodium", "mediaType": "text/html", "description": " Access the FDA dataset for Pentobarbital sodium — ANDA 203619 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203619" } ] |
| identifier | ANDA203619 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "fda", "health-care", "medications", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Pentobarbital sodium |
